Related references
Note: Only part of the references are listed.Reproductive and obstetrical outcomes with the overall survival of fertile-age women treated with fertility-sparing surgery for borderline ovarian tumors in Sweden: a prospective nationwide population based study
Gry Johansen et al.
FERTILITY AND STERILITY (2021)
Fertility-sparing surgery and survival among reproductive-age women with epithelial ovarian cancer in 2 cancer registries
Sarah M. Crafton et al.
CANCER (2020)
Trends in the surgical management of malignant ovarian germcell tumors
Dimitrios Nasioudis et al.
GYNECOLOGIC ONCOLOGY (2020)
Fertility sparing surgery vs radical surgery for epithelial ovarian cancer: a meta-analysis of overall survival and disease-free survival
Denghua Liu et al.
BMC CANCER (2020)
Role of staging surgery and adjuvant chemotherapy in adult patients with apparent stage I pure immature ovarian teratoma after fertility-sparing surgery
Dan Wang et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)
Evaluation of surgical resection in advanced ovarian, fallopian tube, and primary peritoneal cancer: laparoscopic assessment. A European Network of Gynaecological Oncology Trial (ENGOT) group survey
Stefano Greggi et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)
Maintenance olaparib plus bevacizumab (bev) after platinum-based chemotherapy plus bev in patients (pts) with newly diagnosed advanced high-grade ovarian cancer (HGOC): Efficacy by BRCA1 or BRCA2 mutation in the phase III PAOLA-1 trial.
Domenica Lorusso et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Three and Five-Year Mortality in Ovarian Cancer after Minimally Invasive Compared to Open Surgery: A Systematic Review and Meta-Analysis
Floriane Jochum et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Efficacy of Maintenance Olaparib for Patients With Newly Diagnosed Advanced Ovarian Cancer With a BRCA Mutation: Subgroup Analysis Findings From the SOLO1 Trial
Paul DiSilvestro et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline
William P. Tew et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trial
Sarah P Blagden et al.
LANCET ONCOLOGY (2020)
Fertility sparing surgery for patients with FIGO stage I clear cell ovarian carcinoma: a database analysis and systematic review of the literature
Dimitrios Nasioudis et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)
Lymphadenectomy for primary ovarian cancer: a systematic review and meta-analysis
Tatsuyuki Chiyoda et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2020)
Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage
Lauren C. Peres et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage
Lauren C. Peres et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms
Philipp Harter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Prognostic factors and oncological outcomes of ovarian yolk sac tumors: a retrospective multicentric analysis of 99 cases
Gokhan Boyraz et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2019)
Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer
Krishnansu S. Tewari et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study
Joan L. Walker et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Mortality Rates in Laparoscopic and Robotic Gynecologic Oncology Surgery: A Systemic Review and Meta-analysis
Sadikah Behbehani et al.
JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY (2019)
Laparoscopy vs. laparotomy for advanced ovarian cancer: a systematic review of the literature
Salvatore Gueli Alletti et al.
MINERVA MEDICA (2019)
Survival benefits of dose-dense early postoperative intraperitoneal chemotherapy in front-line therapy for advanced ovarian cancer: a randomised controlled study
Tingyan Shi et al.
BRITISH JOURNAL OF CANCER (2019)
Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 study
A. Bergamini et al.
GYNECOLOGIC ONCOLOGY (2019)
The value of surgical staging in patients with apparent early stage epithelial ovarian carcinoma
E. M. Hengeveld et al.
GYNECOLOGIC ONCOLOGY (2019)
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
A. Gonzalez-Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer
R. L. Coleman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer
Antonio Gonzalez Martin et al.
GYNECOLOGIC ONCOLOGY (2019)
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial
Andrew R. Clamp et al.
LANCET (2019)
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer
I. Ray-Coquard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Clinical management of malignant ovarian germ cell tumors: A 26-year experience in a tertiary care institution
Ting Hu et al.
SURGICAL ONCOLOGY-OXFORD (2019)
Minimally invasive interval cytoreductive surgery in ovarian cancer: systematic review and meta-analysis
Joel Cardenas-Goicoechea et al.
JOURNAL OF ROBOTIC SURGERY (2019)
Prognostic factors and effects of fertility-sparing surgery in women of reproductive age with ovarian clear-cell carcinoma: a propensity score analysis
Masato Yoshihara et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2019)
Laparoscopy for primary cytoreduction with multivisceral resections in advanced ovarian cancer: prospective validation. The times they are a-changin?
Marcello Ceccaroni et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2018)
Report of the survey on current opinions and practice of German Society for Gynecologic Endoscopy (AGE) members regarding the laparoscopic treatment of ovarian malignancies
Julia Caroline Radosa et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2018)
Addition of intraperitoneal cisplatin and etoposide to first-line chemotherapy for advanced ovarian cancer: a randomised, phase 2 trial
Tingyan Shi et al.
BRITISH JOURNAL OF CANCER (2018)
Laparoscopic surgery in the treatment of stage I adult granulosa cells tumors of the ovary: Results from the MITO-9 study
A. Bergamini et al.
EJSO (2018)
Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update
Kutluk Oktay et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Survival of selected patients with ovarian cancer treated with fertility-sparing surgery
Nora Elisabeth Hedback et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2018)
Age-dependent difference in impact of fertility preserving surgery on disease-specific survival in women with stage I borderline ovarian tumors
Haiyan Sun et al.
JOURNAL OF OVARIAN RESEARCH (2018)
Analysis of oncologic and reproductive outcomes after fertility-sparing surgery in apparent stage I adult ovarian granulosa cell tumors
Dan Wang et al.
GYNECOLOGIC ONCOLOGY (2018)
Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study
Alexander B. Olawaiye et al.
GYNECOLOGIC ONCOLOGY (2018)
Clinical Outcome After Completion Surgery in Patients With Ovarian Cancer The Charite Experience
Aygun Babayeva et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2018)
Final overall survival (OS) analysis of an international randomized trial evaluating bevacizumab (BEV) in the primary treatment of advanced ovarian cancer: A NRG oncology/Gynecologic Oncology Group (GOG) study
Robert Allen Burger et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Laparoscopic Surgical Algorithm to Triage the Timing of Tumor Reductive Surgery in Advanced Ovarian Cancer
Nicole D. Fleming et al.
OBSTETRICS AND GYNECOLOGY (2018)
Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy
Michael Friedlander et al.
BRITISH JOURNAL OF CANCER (2018)
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
K. Moore et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology/Gynecologic Oncology Group Study
Barbara M. Norquist et al.
CLINICAL CANCER RESEARCH (2018)
Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part I: Indications for fertility preservation
A. N. Schuering et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2018)
The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study
G. Mangili et al.
ANNALS OF ONCOLOGY (2017)
An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience
Kate E. Oliver et al.
GYNECOLOGIC ONCOLOGY (2017)
Management and prognosis of ovarian yolk sac tumors; an analysis of the National Cancer Data Base
Dimitrios Nasioudis et al.
GYNECOLOGIC ONCOLOGY (2017)
Cost-effectiveness of laparoscopy as diagnostic tool before primary cytoreductive surgery in ovarian cancer
Roelien van de Vrie et al.
GYNECOLOGIC ONCOLOGY (2017)
Laparoscopy to Predict the Result of Primary Cytoreductive Surgery in Patients With Advanced Ovarian Cancer: A Randomized Controlled Trial
Marianne J. Rutten et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update
Betty R. Ferrell et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma?
Dimitrios Nasioudis et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2017)
Robotic Versus Laparoscopic Staging for Early Ovarian Cancer: A Case-Matched Control Study
Valerio Gallotta et al.
JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY (2017)
Minimally Invasive Surgical Staging for Ovarian Carcinoma: A Propensity-Matched Comparison With Traditional Open Surgery
Antonino Ditto et al.
JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY (2017)
Minimally Invasive Surgical Staging in Early-stage Ovarian Carcinoma: A Systematic Review and Meta-analysis
Giorgio Bogani et al.
JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY (2017)
Impact of Surgical Route in Influencing the Risk of Lymphatic Complications After Ovarian Cancer Staging
Giorgio Bogani et al.
JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY (2017)
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
Eric Pujade-Lauraine et al.
LANCET ONCOLOGY (2017)
All-Cause Mortality After Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer
Alexander Melamed et al.
OBSTETRICS AND GYNECOLOGY (2017)
Oncofertility in patients with stage I epithelial ovarian cancer: fertility-sparing surgery in young women of reproductive age
Xuan Jiang et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2017)
Fertility-Sparing Surgery Should Be the Standard Treatment in Patients with Malignant Ovarian Germ Cell Tumors
Osman Turkmen et al.
JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY (2017)
Strategies for Introducing Outpatient Specialty Palliative Care in Gynecologic Oncology
Casey M. Hay et al.
JOURNAL OF ONCOLOGY PRACTICE (2017)
Role of laparoscopy in predicting surgical outcomes in patients undergoing interval cytoreduction surgery for advanced ovarian carcinoma: A prospective validation study
Than Singh Tomar et al.
INDIAN JOURNAL OF CANCER (2017)
Laparoscopic staging for apparent stage I epithelial ovarian cancer
Alexander Melamed et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2017)
Early initiation of chemotherapy following complete resection of advanced ovarian cancer associated with improved survival: NRG Oncology/Gynecologic Oncology Group study
K. S. Tewari et al.
ANNALS OF ONCOLOGY (2016)
An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery
Zhi-juan Yang et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2016)
Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): a feasibility study
Salvatore Gueli Alletti et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2016)
Significance of the Complete Surgical Staging of Stage I Malignant Ovarian Germ Cell Tumors
Jeong-Yeol Park et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Long-term results of fertility-sparing treatment compared with standard radical surgery for early-stage epithelial ovarian cancer
Robert Fruscio et al.
BRITISH JOURNAL OF CANCER (2016)
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
Melinda L. Telli et al.
CLINICAL CANCER RESEARCH (2016)
Sensor-controlled scalp cooling to prevent chemotherapy-induced alopecia in female cancer patients
M. K. Fehr et al.
CURRENT ONCOLOGY (2016)
Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome
Anna Fagotti et al.
EUROPEAN JOURNAL OF CANCER (2016)
Laparoscopic surgical staging in women with early stage epithelial ovarian cancer performed by recently certified gynecologic oncologists
Lucas Minig et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2016)
Minimally invasive versus standard laparotomic interval debulking surgery in ovarian neoplasm: A single-institution retrospective case-control study
S. Gueli Alletti et al.
GYNECOLOGIC ONCOLOGY (2016)
Interval Laparoscopic En-Bloc Resection of the Pelvis (L-EnBRP) in patients with stage IIIC-IV ovarian cancer: Description of the technique and surgical outcomes
Roberto Tozzi et al.
GYNECOLOGIC ONCOLOGY (2016)
Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline
Alexi A. Wright et al.
GYNECOLOGIC ONCOLOGY (2016)
Incidence of Lymph Node Metastases in Apparent Early-Stage Low-Grade Epithelial Ovarian Cancer: A Comprehensive Review
Victor Lago et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2016)
The effect of lymphadenectomy on survival and recurrence in patients with ovarian cancer: a systematic review and meta-analysis
Jinhong Zhou et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2016)
Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials
Dawn L. Hershman et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Laparoscopic Management of Ovarian Cancer Patients With Localized Carcinomatosis and Lymph Node Metastases: Results of a Retrospective Multi-institutional Series
Valerio Gallotta et al.
JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY (2016)
Comparison of Laparoscopy and Laparotomy in Surgical Staging of Apparent Early Ovarian Cancer 13-year Experience
Qi Lu et al.
MEDICINE (2016)
Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer
J. K. Chan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Distribution and case-fatality ratios by cell-type for ovarian carcinomas: A 22-year series of 562 patients with uniform current histological classification
Jeffrey D. Seidman et al.
GYNECOLOGIC ONCOLOGY (2015)
Risk factors for readmission in patients with ovarian, fallopian tube, and primary peritoneal carcinoma who are receiving front-line chemotherapy on a clinical trial (GOG 218): an NRG oncology/gynecologic oncology group study (ADS-1236)
Linda R. Duska et al.
GYNECOLOGIC ONCOLOGY (2015)
Improving quality and decreasing cost in gynecologic oncology care. Society of gynecologic oncology recommendations for clinical practice
B. J. Rimel et al.
GYNECOLOGIC ONCOLOGY (2015)
Ovarian cancer in the United States: Contemporary patterns of care associated with improved survival
William A. Cliby et al.
GYNECOLOGIC ONCOLOGY (2015)
Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: An NRG Oncology/GOG study
James S. Ferriss et al.
GYNECOLOGIC ONCOLOGY (2015)
Adjuvant Hormone Therapy May Improve Survival in Epithelial Ovarian Cancer: Results of the AHT Randomized Trial
Rosalind A. Eeles et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer: A Gynecologic Oncology Group Study
Devansu Tewari et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Major clinical research advances in gynecologic cancer in 2014
Dong Hoon Suh et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2015)
Impact of National Cancer Institute Comprehensive Cancer Centers on Ovarian Cancer Treatment and Survival
Robert E. Bristow et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2015)
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
Sean Kehoe et al.
LANCET (2015)
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
Amit M. Oza et al.
LANCET ONCOLOGY (2015)
Oncologic Concerns regarding Laparoscopic Cytoreductive Surgery in Patients with Advanced Ovarian Cancer Submitted to Neoadjuvant Chemotherapy
Giovanni Favero et al.
ONCOLOGY (2015)
Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs
Andrea M. Marquard et al.
BIOMARKER RESEARCH (2015)
Lymphadenectomy in surgical stage I epithelial ovarian cancer
Olivia Svolgaard et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2014)
Influence of Intraperitoneal Dissemination Assessed by Laparoscopy on Prognosis of Advanced Ovarian Cancer: An Exploratory Analysis of a Single-Institution Experience
Giuseppe Vizzielli et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Reasons for failure to deliver National Comprehensive Cancer Network (NCCN)-adherent care in the treatment of epithelial ovarian cancer at an NCCN cancer center
Britt K. Erickson et al.
GYNECOLOGIC ONCOLOGY (2014)
Laparoscopic and Open Abdominal Staging for Early-Stage Ovarian Cancer Our Experience, Systematic Review, and Meta-analysis of Comparative Studies
Giorgio Bogani et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2014)
Risk Factors for GI Adverse Events in a Phase III Randomized Trial of Bevacizumab in First-Line Therapy of Advanced Ovarian Cancer: A Gynecologic Oncology Group Study
Robert A. Burger et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Laparoscopy-Assisted Supracervical Hysterectomy for Ovarian Cancer: Cervical Recurrence
James Fanning et al.
JSLS-JOURNAL OF THE SOCIETY OF LAPAROENDOSCOPIC SURGEONS (2014)
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial
Sandro Pignata et al.
LANCET ONCOLOGY (2014)
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience
Valerio Gallotta et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2014)
Association of BRCA1/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes
Kirsten M. Timms et al.
BREAST CANCER RESEARCH (2014)
Staging laparoscopy for the management of early-stage ovarian cancer: a metaanalysis
Hyun Jong Park et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2013)
A multicentric trial (Olympia-MITO 13) on the accuracy of laparoscopy to assess peritoneal spread in ovarian cancer
Anna Fagotti et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2013)
A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCOTROC 4) and ANZGOG study on behalf of GCIG
S. Banerjee et al.
ANNALS OF ONCOLOGY (2013)
Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
J. A. Ledermann et al.
ANNALS OF ONCOLOGY (2013)
Long-term follow-up is crucial after treatment for granulosa cell tumours of the ovary
G. Mangili et al.
BRITISH JOURNAL OF CANCER (2013)
Laparoscopic staging for apparent early stage ovarian or fallopian tube cancer. First case series from a UK cancer centre and systematic literature review
E. C. Brockbank et al.
EJSO (2013)
Which patients benefit most from primary surgery or neoadjuvant chemotherapy in stage IIIC or IV ovarian cancer? An exploratory analysis of the European Organisation for Research and Treatment of Cancer 55971 randomised trial
Hannah S. van Meurs et al.
EUROPEAN JOURNAL OF CANCER (2013)
Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: Impact on prognosis in a single institution experience
A. Fagotti et al.
GYNECOLOGIC ONCOLOGY (2013)
Patient reported outcomes of a randomized, placebo-controlled trial of bevacizumab in the front-line treatment of ovarian cancer: A Gynecologic Oncology Group Study
Bradley J. Monk et al.
GYNECOLOGIC ONCOLOGY (2013)
Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: A Gynecologic Oncology Group study
Lisa M. Landrum et al.
GYNECOLOGIC ONCOLOGY (2013)
Clinical impact of systematic pelvic and para-aortic lymphadenectomy for pT1 and pT2 ovarian cancer: a retrospective survey by the Sankai Gynecology Study Group
Takafumi Oshita et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2013)
Accuracy and Reproducibility of the Peritoneal Cancer Index in Advanced Ovarian Cancer During Laparoscopy and Laparotomy
Sebastien Gouy et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial
Dan Stark et al.
LANCET ONCOLOGY (2013)
Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial
Noriyuki Katsumata et al.
LANCET ONCOLOGY (2013)
Adherence to Treatment Guidelines for Ovarian Cancer as a Measure of Quality Care
Robert E. Bristow et al.
OBSTETRICS AND GYNECOLOGY (2013)
Palliative systemic therapy for women with recurrent epithelial ovarian cancer: current options
Laurie Elit et al.
ONCOTARGETS AND THERAPY (2013)
First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)-a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG
K. Lindemann et al.
ANNALS OF ONCOLOGY (2012)
Systematic Para-aortic and Pelvic Lymphadenectomy in Early Stage Epithelial Ovarian Cancer: A Prospective Study
Antonino Ditto et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Laparoscopy to predict the result of primary cytoreductive surgery in advanced ovarian cancer patients (LapOvCa-trial): a multicentre randomized controlled study
Marianne J. Rutten et al.
BMC CANCER (2012)
Systematic lymphadenectomy in ovarian cancer at second-look surgery: a randomised clinical trial
T. Dell' Anna et al.
BRITISH JOURNAL OF CANCER (2012)
Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer
V. Abkevich et al.
BRITISH JOURNAL OF CANCER (2012)
Ploidy and Large-Scale Genomic Instability Consistently Identify Basal-like Breast Carcinomas with BRCA1/2 Inactivation
Tatiana Popova et al.
CANCER RESEARCH (2012)
Treatment of Ovarian Cancer in Young Women
David M. Gershenson
CLINICAL OBSTETRICS AND GYNECOLOGY (2012)
Management of a suspicious adnexal mass: a clinical practice guideline
J. E. Dodge et al.
CURRENT ONCOLOGY (2012)
Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer
Joyce N. Barlin et al.
GYNECOLOGIC ONCOLOGY (2012)
Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: Redefining 'optimal' residual disease
Suk-Joon Chang et al.
GYNECOLOGIC ONCOLOGY (2012)
Surgical management of a suspicious adnexal mass: A systematic review
Allan L. Covens et al.
GYNECOLOGIC ONCOLOGY (2012)
Current Surgical Management of Ovarian Cancer
John O. Schorge et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2012)
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
Jonathan Ledermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents
Nicolai J. Birkbak et al.
CANCER DISCOVERY (2012)
Increasing experience in laparoscopic staging of early ovarian cancer
Henk W. R. Schreuder et al.
GYNECOLOGICAL SURGERY (2012)
Phase II trial of intraperitoneal cisplatin combined with intravenous paclitaxel in patients with ovarian, primary peritoneal and fallopian tube cancer
Lisa M. Landrum et al.
GYNECOLOGIC ONCOLOGY (2011)
Fertility-Sparing Surgery for Borderline Ovarian Tumors Oncologic Safety and Reproductive Outcomes
Taejong Song et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2011)
Carboplatin Plus Paclitaxel Versus Carboplatin Plus Pegylated Liposomal Doxorubicin As First-Line Treatment for Patients With Ovarian Cancer: The MITO-2 Randomized Phase III Trial
Sandro Pignata et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Clinicopathologic characteristics of granulosa cell tumors of the ovary: a multicenter retrospective study
In Ho Lee et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2011)
Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
Karen A. Gelmon et al.
LANCET ONCOLOGY (2011)
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
Robert A. Burger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A Phase 3 Trial of Bevacizumab in Ovarian Cancer
Timothy J. Perren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Revised RECIST Guideline Version 1.1: What Oncologists Want to Know and What Radiologists Need to Know
Mizuki Nishino et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2010)
Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III-IV epithelial ovarian cancer a multicenter, randomized study
Giorgio Bolis et al.
EUROPEAN JOURNAL OF CANCER (2010)
Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery?
A. Fagotti et al.
GYNECOLOGIC ONCOLOGY (2010)
The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: An exploratory analysis of a Gynecologic Oncology Group study
John K. Chan et al.
GYNECOLOGIC ONCOLOGY (2010)
Systematic Lymphadenectomy for Survival in Epithelial Ovarian Cancer A Meta-Analysis
Hee Seung Kim et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2010)
Outcomes of Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer: A Proposal for Patient Selection
Toyomi Satoh et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase III Trial of Carboplatin Plus Paclitaxel With or Without Gemcitabine in First-Line Treatment of Epithelial Ovarian Cancer
Andreas du Bois et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval
Peter C. Fong et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Potential Role of Lymphadenectomy in Advanced Ovarian Cancer: A Combined Exploratory Analysis of Three Prospectively Randomized Phase III Multicenter Trials
Andreas du Bois et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Advanced Ovarian Cancer: Phase III Randomized Study of Sequential Cisplatin-Topotecan and Carboplatin-Paclitaxel vs Carboplatin-Paclitaxel
P. Hoskins et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
The Safety and Efficacy of Laparoscopic Surgical Staging and Debulking of Apparent Advanced Stage Ovarian, Fallopian Tube, and Primary Peritoneal Cancers
Farr R. Nezhat et al.
JSLS-JOURNAL OF THE SOCIETY OF LAPAROENDOSCOPIC SURGEONS (2010)
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
M. William Audeh et al.
LANCET (2010)
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
Ignace Vergote et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Lymph node metastasis in grossly apparent clinical stage Ia epithelial ovarian cancer: Hacettepe experience and review of literature
Guldeniz Aksan Desteli et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2010)
Review: Practical considerations in ovarian cancer chemotherapy
Mihaela Cristea et al.
Therapeutic Advances in Medical Oncology (2010)
Fertility Preservation in Young Women With Epithelial Ovarian Cancer
Jason D. Wright et al.
CANCER (2009)
Update on nonhormonal approaches to menopausal management.
M. R Jenkins et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Pattern of retroperitoneal dissemination of primary peritoneum cancer: Basis for rational use of lymphadenectomy
Giovanni D. Aletti et al.
GYNECOLOGIC ONCOLOGY (2009)
Surgical management of borderline ovarian tumors: The role of fertility-sparing surgery
Jeong-Yeol Park et al.
GYNECOLOGIC ONCOLOGY (2009)
Cytoreductive surgery for recurrent ovarian cancer: A meta-analysis
Robert E. Bristow et al.
GYNECOLOGIC ONCOLOGY (2009)
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm
Dennis S. Chi et al.
GYNECOLOGIC ONCOLOGY (2009)
Long-Term Survival After Fertility-Sparing Surgery for Epithelial Ovarian Cancer
Alan C. Schlaerth et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup
Michael A. Bookman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Laparoscopy and Ovarian Cancer: A Paradigm Change in the Management of Ovarian Cancer?
Connie S. Liu et al.
JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY (2009)
Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial
Noriyuki Katsumata et al.
LANCET (2009)
Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma
Anna Fagotti et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2008)
Comparison of laparoscopy and laparotomy in surgical staging of early-stage ovarian and fallopian tubal cancer
Jeong-Yeol Park et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Should adnexal mass size influence surgical approach? A series of 186 laparoscopically managed large adnexal masses
F. Ghezzi et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2008)
The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer
Eric L. Eisenhauer et al.
GYNECOLOGIC ONCOLOGY (2008)
Laparoscopic and laparotomic staging in stage I epithelial ovarian cancer: a comparison of feasibility and safety
J. -Y. Park et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
Laparoscopic treatment and staging of early ovarian cancer
Anna Torrent Colomer et al.
JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY (2008)
The influence of conservative surgical practices for malignant ovarian germ cell tumors
John K. Chan et al.
JOURNAL OF SURGICAL ONCOLOGY (2008)
Phase III Randomized trial of intravenous cisplatin plus a 24-or 96-hour infusion of paclitaxel in epithelial ovarian cancer: gynecologic oncology group study
David R. Spriggs et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase III trial of high-dose sequential chemotherapy with peripheral blood stem cell support compared with standard dose chemotherapy for first-line treatment of advanced ovarian cancer:: Intergroup trial of the AGO-Ovar/AIO and EBMT
Volker Moebus et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Role of surgery in ovarian carcinoma
Amanda Nickles Fader et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Prognostic factors responsible for survival in sex cord stromal tumors of the ovary- An analysis of 376 women
Mallory Zhang et al.
GYNECOLOGIC ONCOLOGY (2007)
Feasibility, toxicity and quality of life of first-line chemotherapy with platinum/paclitaxel in elderly patients aged ≥70 years with advanced ovarian cancer -: a study by the AGO OVAR Germany
F. Hilpert et al.
ANNALS OF ONCOLOGY (2007)
The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer
Eric L. Eisenhauer et al.
GYNECOLOGIC ONCOLOGY (2006)
Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis
A. Maggioni et al.
BRITISH JOURNAL OF CANCER (2006)
Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: A Gynecologic Oncology Group study
Jeffrey Bell et al.
GYNECOLOGIC ONCOLOGY (2006)
Randomized phase III trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer:: A gynecologic cancer intergroup trial of the AGO-OVAR and GINECO
Jacobus Pfisterer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Randomized study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group comparing quality of life in patients with ovarian cancer treated with cisplatin/paclitaxel versus carboplatin/paclitaxel
ER Greimel et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients
CC Earle et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Intraperitoneal cisplatin and paclitaxel in ovarian cancer
DK Armstrong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Impact of initial surgical access on staging and survival of patients with stage I ovarian cancer
F Lecuru et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)
Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intrapentoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: A Gynecologic Oncology Group study
JL Walker et al.
GYNECOLOGIC ONCOLOGY (2006)
Aggressive surgical effort and improved survival in advanced-stage ovarian cancer
GD Aletti et al.
OBSTETRICS AND GYNECOLOGY (2006)
Who should operate on patients with ovarian cancer? An evidence-based review
KC Giede et al.
GYNECOLOGIC ONCOLOGY (2005)
Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer: long-term efficacy results: a Hellenic Cooperative Oncology Group (HeCOG) study
G Aravantinos et al.
ANNALS OF ONCOLOGY (2005)
The safety and efficacy of laparoscopic surgical staging of apparent stage I ovarian and fallopian tube cancers
DS Chi et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: A randomized clinical trial
PB Panici et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: An intergroup study
D Billmire et al.
JOURNAL OF PEDIATRIC SURGERY (2004)
Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma
PA Vasey et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer
A du Bois et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A Gynecologic Oncology Group study
RF Ozols et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
First-line intraperitoneal carboplatin-based chemotherapy for 165 patients with epithelial ovarian carcinoma: results of long-term follow-up
K Fujiwara et al.
GYNECOLOGIC ONCOLOGY (2003)
Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm Trial
JB Trimbos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy
JM Schilder et al.
GYNECOLOGIC ONCOLOGY (2002)
Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma
I Vergote et al.
LANCET (2001)
Laparoscopic surgery for complex ovarian masses
U Ulrich et al.
JOURNAL OF THE AMERICAN ASSOCIATION OF GYNECOLOGIC LAPAROSCOPISTS (2000)
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: Three-year results
MJ Piccart et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: A randomized trial of the Gruppo Oncologico Noud-Ovest
A Gadducci et al.
GYNECOLOGIC ONCOLOGY (2000)
Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: A gynecologic oncology group study
FM Muggia et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer
JP Neijt et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument
C Trope et al.
ANNALS OF ONCOLOGY (2000)
Share Paper
